Ledger.Open graph →

SEC Form D · filed December 22, 2016

Cue Biopharma, Inc

Offering

$20.0M

Sold

$20.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Cameron Gray · CAMBRIDGE, MADirector Anthony Digiandomenico · CAMBRIDGE, MADirector Rodolfo Chaparro · CAMBRIDGE, MAExec Barry Simon · CAMBRIDGE, MADirector Amy Wang · CAMBRIDGE, MADirector Christopher Marlett · CAMBRIDGE, MADirector Daniel Passeri · CAMBRIDGE, MAExec · Director Ronald Seidel Iii · CAMBRIDGE, MAExec Steven Mcknight · CAMBRIDGE, MADirector Peter Kiener · CAMBRIDGE, MADirector Gary Schuman · CAMBRIDGE, MAExec Dovey Wan · CUPERTINO, CADirector Mitchell Liu · CUPERTINO, CADirector Ron Fischer · New York, NYDirector Paul Segal · New York, NYExec Christian Sugiarto · Hong Kong, IsraelExec Joel J. Schwartz · NEW YORK, NYExec Mikhail Segal · New York, NYDirector Ridwan Budijono · Hong Kong, IsraelExec · Director Lanham Napier · Austin, TXDirector Kenneth Herz · Austin, TXDirector James L. Curry · Austin, TXExec · Director Andrea R. Bruno · Maitland, FLDirector Troy W. Eckard · Allen, TXDirector Padraig Hoare · George Town, Cayman IslandsExec · Director Fabio Rosati · Seattle, WADirector Kyla Fullenwider · Seattle, WADirector Elaine Mason · Seattle, WADirector Peter E. Mogk · DETROIT, MIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗